Page last updated: 2024-08-21

megestrol acetate and Obesity

megestrol acetate has been researched along with Obesity in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Liu, Z; Niu, J; Shi, C; Zhao, X	1
Bi, Y; Chen, M; Jin, Y; Li, Y; Pan, L; Shan, Y	1
Mizushima, Y; Murakami, T	1

Reviews

1 review(s) available for megestrol acetate and Obesity

Article	Year
[Drug induced obesity]. Nihon rinsho. Japanese journal of clinical medicine, 1995, Volume: 53 Suppl Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents, Hormonal; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Male; Megestrol; Megestrol Acetate; Obesity; Psychotropic Drugs; Tamoxifen	1995

Trials

1 trial(s) available for megestrol acetate and Obesity

Article	Year
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr Reproductive health, 2022, Nov-04, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic	2022

Article

Year

Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr

Reproductive health, 2022, Nov-04, Volume: 19, Issue:1

Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic

2022

Other Studies

1 other study(ies) available for megestrol acetate and Obesity

Article	Year
Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016, Volume: 132, Issue:1 Topics: Adult; Antineoplastic Agents, Hormonal; China; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Obesity; Pregnancy; Progestins; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult	2016

Article

Year

Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016, Volume: 132, Issue:1

Topics: Adult; Antineoplastic Agents, Hormonal; China; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Obesity; Pregnancy; Progestins; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult

2016